Beam Therapeutics BEAM
NASDAQ BEAM
$24.52 +0.29 (+1.20%)
At close: Sep 29, 2026 · 4:00 PM EDT

Beam Therapeutics (BEAM) Capital Expenditures (2019 - 2026)

Updated

Beam Therapeutics (BEAM) recorded Capital Expenditures of $2.41 million in Q2 2026, down 23.0% from $3.14 million a year earlier but up 8.2% from the prior quarter.

Analysis

Beam Therapeutics (BEAM) Capital Expenditures (2019 - 2026) Analysis & Trends

On a TTM basis, Beam Therapeutics' Capital Expenditures came in at $13.39 million as of Jun 30, 2026, up 24.6% year-over-year; for FY2025, it was $14.95 million, up 67.1% from FY2024.

  • Annual Capital Expenditures has a five-year compound annual growth rate of -1.8% (FY2020 to FY2025).
  • Across earlier years, Capital Expenditures came in at $8.95 million in FY2024 (-73.5%), $33.73 million in FY2023 (-31.1%), $48.95 million in FY2022 (+4.6%) and $46.81 million in FY2021 (+186.2%).
  • Quarterly Capital Expenditures has ranged from $1.58 million in Q3 2024 to $21.64 million in Q2 2022 over the past five years.
  • On a year-over-year basis, Capital Expenditures rose in four of the last eight quarters, with growth averaging 22.7%.
  • Peak year-over-year performance for Capital Expenditures in the last five years was growth of 217.8% in Q3 2025, against a decline of 87.9% in Q2 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $2.23 million (Q1 2026), $3.73 million (Q4 2025) and $5.01 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 1.32 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 322.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -763.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 112.20 Mn
10 Beam Therapeutics 2.50 Bn 2.50 Bn - 2.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.41 Mn
Mar 31, 2026 2.23 Mn
Dec 31, 2025 3.73 Mn
Sep 30, 2025 5.01 Mn
Jun 30, 2025 3.14 Mn
Mar 31, 2025 3.07 Mn
Dec 31, 2024 2.97 Mn
Sep 30, 2024 1.58 Mn
Jun 30, 2024 1.96 Mn
Mar 31, 2024 2.44 Mn
Dec 31, 2023 3.59 Mn
Sep 30, 2023 7.95 Mn
Jun 30, 2023 16.18 Mn
Mar 31, 2023 6.02 Mn
Dec 31, 2022 8.26 Mn
Sep 30, 2022 11.79 Mn
Jun 30, 2022 21.64 Mn
Mar 31, 2022 7.26 Mn
Dec 31, 2021 13.37 Mn
Sep 30, 2021 5.78 Mn
API Access

Beam Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=BEAM&period=max&api_key=YOUR_API_KEY